General Notices

• Notice of the Extension of the Response Date for NOT-DK-23-011: "NIDDK seeks public comment on the Report of the NIDDK Advisory Council Working Group on Health Disparities and Health Equity Research"
  (NOT-DK-23-016)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Request for Information (RFI): Strategies to Expand and Enhance Development of the Molecular Cancer Prevention and Cancer Interception Research Workforce
  (NOT-CA-23-053)
  National Cancer Institute
  

Notice of Changes to Funding Opportunities

• Notice of Change to the Page Limitations Information Listed in RFA-AG-24-010, "Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed)"
  (NOT-AG-23-016)
  National Institute on Aging
  

• Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-23-067, Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
  (NOT-AI-23-035)
  National Institute of Allergy and Infectious Diseases
  

• Notice to Extend NCCIH's PAR-20-154, "Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)"
  (NOT-AT-24-002)
  National Center for Complementary and Integrative Health
  

• Notice of Change to Application Due Date for RFA-CA-23-025 "Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)"
  (NOT-CA-23-051)
  National Cancer Institute
  

• Clarification of Eligibility for Institutions with Multiple Campuses in PAR-22-212 "Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)"
  (NOT-GM-23-018)
  National Institute of General Medical Sciences
  

• Clarification of Eligibility for Institutions with Multiple Campuses in PAR-20-213 "National Institute of General Medical Sciences Predoctoral Institutional Research Training Grant (T32 - Clinical Trial Not Allowed)"
  (NOT-GM-23-024)
  National Institute of General Medical Sciences
  

• Notice of Change: Additional Receipt Dates for PAR-22-092, "Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional)"
  (NOT-MD-23-010)
  National Institute on Minority Health and Health Disparities
  National Institute on Drug Abuse
  

• Notice of NINDS Participation in RFA-ES-23-007 "Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)"
  (NOT-NS-23-078)
  National Institute of Neurological Disorders and Stroke
  National Institute of Environmental Health Sciences
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Early-stage Data Repositories and Knowledgebases (Clinical Trials Not Allowed)
  (NOT-OD-23-093)
  Office of the Director, NIH
  

Requests for Proposal

• Pre-Solicitation Notice: External Quality Assurance Program Oversight Laboratory (EQAPOL), RFP: 75N93022R00034
  (NOT-AI-23-036)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplement for Tackling Acquisition of Language in Kids (TALK) Initiative
  (NOT-DC-23-005)
  National Institute on Deafness and Other Communication Disorders
  National Center for Advancing Translational Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): Competitive Revisions for Maintenance and Integration of the Encyclopedia of DNA Elements (ENCODE) Data Resource
  (NOT-HG-23-023)
  National Human Genome Research Institute
  

• Notice of Special Interest (NOSI): Research supplements to enhance utility and usage of Common Fund datasets
  (NOT-RM-23-006)
  Office of Strategic Coordination (Common Fund)
  

Funding Opportunities

• Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
  (PAR-22-265)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NINDS Institutional AD/ADRD Research Training Program (T32 Clinical Trial Not Allowed)
  (PAR-23-113)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): May 25, 2024
  
  

• Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
  (PAR-23-138)
  National Institute of General Medical Sciences
  National Center for Advancing Translational Sciences
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Office of the Director, NIH
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): June 02, 2025
  
  

• CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
  (PAR-23-139)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): May 30, 2025
  
  

• NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
  (PAR-23-269)
  National Institute on Drug Abuse
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Defining Mechanisms of HIV Induced Inflammation and Immune Activation During Suppressive Antiretroviral Therapy (ART) (R01 Clinical Trial Not Allowed)
  (RFA-AI-23-018)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Not Applicable
  
  

• Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-CA-23-028)
  National Cancer Institute
  Application Receipt Date(s): June 13, 2025
  
  

• Novel Approaches for Developmental Neurotoxicity Testing (R43/R44 Clinical Trial Not Allowed)
  (RFA-ES-23-008)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): July 07, 2023
  
  

• Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
  (RFA-MH-23-140)
  National Institute of Mental Health
  Application Receipt Date(s): June 21, 2023
  
  

• Integration and Coordination Center for the Common Fund Data Ecosystem (U54 Clinical Trial Not Allowed)
  (RFA-RM-23-002)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): June 28, 2023
  
  

• Limited Competition: Molecular Transducers of Physical Activity Bioinformatics Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-23-008)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): May 15, 2023
  
  

• Limited Competition: Molecular Transducers of Physical Activity Chemical Analysis Sites (U24 Clinical Trial Not Allowed)
  (RFA-RM-23-009)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): May 15, 2023
  
  

• Limited Competition: Molecular Transducers of Physical Activity Clinical Centers (U01 Clinical Trial Required)
  (RFA-RM-23-010)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): May 15, 2023
  
  

• Limited Competition: Molecular Transducers of Physical Activity Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-RM-23-011)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): May 15, 2023